97 related articles for article (PubMed ID: 21478336)
1. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified.
Niitsu N; Nakamine H; Okamoto M
Clin Cancer Res; 2011 May; 17(9):2893-9. PubMed ID: 21478336
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
3. Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
Niitsu N; Hayama M; Yoshino T; Nakamura S; Tamaru J; Nakamine H; Okamoto M
Br J Haematol; 2011 Jun; 153(5):582-8. PubMed ID: 21492124
[TBL] [Abstract][Full Text] [Related]
4. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
[TBL] [Abstract][Full Text] [Related]
5. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
Niitsu N
J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
[TBL] [Abstract][Full Text] [Related]
6. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
7. CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified.
Gazzola A; Sista MT; Agostinelli C; Righi S; Sapienza MR; Mannu C; Rossi M; Bacci F; Sabattini E; Went P; Zinzani PL; Pileri SA; Piccaluga PP
J Clin Pathol; 2011 Jan; 64(1):83-7. PubMed ID: 21045237
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
9. Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells.
Okabe-Kado J; Kasukabe T; Honma Y; Kobayashi H; Maseki N; Kaneko Y
Cancer Sci; 2009 Oct; 100(10):1885-94. PubMed ID: 19664043
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
13. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified.
Yamada S; Sato F; Xia H; Takino H; Kominato S; Ri M; Ishida T; Iida S; Inagaki H; Yamada K
Hum Pathol; 2012 Aug; 43(8):1322-7. PubMed ID: 22401769
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
Shibata Y; Hara T; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Goto N; Nannya Y; Ito H; Kito Y; Miyazaki T; Takeuchi T; Saito K; Seishima M; Takami T; Moriwaki H; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Dec; 35(4):637-644. PubMed ID: 27338762
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
17. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T; Paterson JC; Ballabio E; Chott A; Natkunam Y; Rodriguez-Justo M; Plonquet A; Rodriguez-Pinilla SM; Klapper W; Hansmann ML; Pileri SA; Isaacson PG; Stein H; Piris MA; Mason DY; Gaulard P
Haematologica; 2010 Mar; 95(3):432-9. PubMed ID: 20207847
[TBL] [Abstract][Full Text] [Related]
18. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
Zhang T; Lai Q; Du D
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
[TBL] [Abstract][Full Text] [Related]
19. A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified.
Li Q; Gao S; Ma J; Liu S; Yue Y; Chen L; Li H; Wang X; Li D; Cao Z; Zhao Z; Wang X; Yu Y; Zhang Y; Wang Y
Leuk Res; 2018 Oct; 73():5-11. PubMed ID: 30172956
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]